Current Drug Targets - CNS & Neurological Disorders
Title: Preface [Hot Topic: Novel Therapeutics for the Treatment of Pain (Guest Editor: Kathleen R. Gogas)]
Volume: 3 Issue: 6
Author(s): Kathleen R. Gogas
Affiliation:
Export Options
About this article
Cite this article as:
Gogas R. Kathleen, Preface [Hot Topic: Novel Therapeutics for the Treatment of Pain (Guest Editor: Kathleen R. Gogas)], Current Drug Targets - CNS & Neurological Disorders 2004; 3 (6) . https://dx.doi.org/10.2174/1568007043336851
DOI https://dx.doi.org/10.2174/1568007043336851 |
Print ISSN 1568-007X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-007X |
13
Related Articles
-
Pathophysiology of Blood-Brain Barrier in Brain Injury in Cold and Hot Environments: Novel Drug Targets for Neuroprotection
CNS & Neurological Disorders - Drug Targets Proteasome Structure, Function, and Lessons Learned from Beta-Lactone Inhibitors
Current Topics in Medicinal Chemistry Tracing the Origins of COX-2 Inhibitors Structures+
Current Medicinal Chemistry Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
Current Neuropharmacology Prebiotics: A New Hope Against Antibiotic Associated Diarrhea
Anti-Infective Agents Evaluation of Pregabalin Therapy in Peripheral Neuropathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Mechanisms for Radioprotection by Melatonin; Can it be Used as a Radiation Countermeasure?
Current Molecular Pharmacology Prayer at Midlife is Associated with Reduced Risk of Cognitive Decline in Arabic Women
Current Alzheimer Research GPR40 Carboxylic Acid Receptor Family and Diabetes: A New Drug Target
Current Drug Targets LPS Up-Regulates Cystathionine γ -Lyase Gene Expression in Primary Human Macrophages via NF-κB/ERK Pathway
Inflammation & Allergy - Drug Targets (Discontinued) AMP-activated Protein Kinase As a Target For Pathogens: Friends Or Foes?
Current Drug Targets Cardioprotective effects of Aronia melanocarpa anthocynanins. From laboratory experiments to clinical practice.
Current Pharmaceutical Design Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases
Current Medicinal Chemistry Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Current Pharmaceutical Design EDITORIAL [Hot topic: Tissue Fibrosis (Guest Editor: Shizuya Saika)]
Endocrine, Metabolic & Immune Disorders - Drug Targets Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells
Current Pharmaceutical Design Synthesis and Bioactivity of (R)-Ricinoleic Acid Derivatives: A Review
Current Medicinal Chemistry Old Friends in New Constellations - the Hematopoetic Growth Factors G-CSF, GMCSF, and EPO for the Treatment of Neurological Diseases
Current Medicinal Chemistry Targeting Synthetic Lethality in DNA Damage Repair Pathways as an Anti-Cancer Strategy
Current Drug Targets The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies
Central Nervous System Agents in Medicinal Chemistry